Anteris Technologies Global Corp. (AVR)
NASDAQ: AVR · Real-Time Price · USD
5.99
-0.01 (-0.17%)
Jan 17, 2025, 4:00 PM EST - Market closed
AVR Revenue
Anteris Technologies Global had revenue of $768.98K in the quarter ending September 30, 2024, a decrease of -5.05%. This brings the company's revenue in the last twelve months to $2.83M, down -1.52% year-over-year. In the year 2023, Anteris Technologies Global had annual revenue of $4.11M, down -10.43%.
Revenue (ttm)
$2.83M
Revenue Growth
-1.52%
P/S Ratio
n/a
Revenue / Employee
$20,483
Employees
138
Market Cap
212.68M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 4.11M | -478.97K | -10.43% |
Dec 31, 2022 | 4.59M | -3.20M | -41.08% |
Dec 31, 2021 | 7.79M | 712.17K | 10.06% |
Dec 31, 2020 | 7.08M | -10.00M | -58.54% |
Dec 31, 2019 | 17.08M | -8.53M | -33.30% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 87.70B |
Merck & Co. | 63.17B |
AbbVie | 55.53B |
AstraZeneca | 51.21B |
Novartis AG | 49.94B |
Thermo Fisher Scientific | 42.37B |
Abbott Laboratories | 41.22B |
AVR News
- 5 weeks ago - Anteris Technologies Global Corp. Announces Pricing of U.S. Initial Public Offering - Business Wire
- 6 weeks ago - Anteris Technologies Global Corp. Announces Launch of U.S. Initial Public Offering - Business Wire
- 2 months ago - Cardiac device maker Anteris Technologies files for $75M IPO - Seeking Alpha
- 2 months ago - Australian medical device company Anteris Technologies Global files for a $75 million US IPO - Renaissance Capital
- 2 months ago - Anteris Technologies Global IPO Registration Document (S-1) - SEC.gov